National Heart, Lung, and Blood Institute; Amended Notice of Meeting, 4522 [07-398]

Download as PDF 4522 Federal Register / Vol. 72, No. 20 / Wednesday, January 31, 2007 / Notices Dated: January 23, 2007. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 07–401 Filed 1–30–07; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings mstockstill on PROD1PC62 with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Initial Review Group; Subcommittee 1—Career Development. Date: February 27–28, 2007. Time: 8 a.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: The Hilton Alexandria Old Town, 1767 King Street, Alexandria, VA 22314. Contact Person: Robert Bird, PhD, Scientific Review Administrator, Resources and Training Review Branch, National Cancer Institute, National Institutes of Health, 6116 Executive Blvd., Room 8113, MSC 8328, Bethesda, MD 20892–8328, 301– 496–7978, birdr@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Innovative Technologies for Molecular Analysis of Cancer. Date: March 7–8, 2007. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814. Contact Person: Sherwood Githens, PhD, Scientific Review Administrator, Special Review and Logistics Branch, National Cancer Institute, Division of Extramural Activities, 6116 Executive Blvd., Room 8053, Bethesda, MD 20892, 301–435–1822, githenss@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, TW06–006 ‘‘International Tobacco and Health Research and Building Capacity.’’ Date: March 20–21, 2007. VerDate Aug<31>2005 15:08 Jan 30, 2007 Jkt 211001 Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Courtyard Gaithersburg Washingtonian Center, 204 Boardwalk Place, Gaithersburg, MD 20878. Contact Person: Gerald G. Lovinger, PhD, Scientific Review Administrator, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Blvd., Room 8101, Bethesda, MD 20892–8329, 301–496–7987, lovingeg@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: January 23, 2007. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 07–402 Filed 1–30–07; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Heart, Lung, and Blood Institute Special Emphasis Panel, February 23, 2007, 8:30 a.m. to February 23, 2007, 3 p.m., Embassy Suites Hotel Washington Convention Ctr., Washington, DC 20001 which was published in the Federal Register on January 12, 2007, FR 07–100. The February 23, 2007 Meeting Panel Name was changed from Modified Hemoglobin Production to VAD Technologies. The meeting is closed to the public. Dated: January 24, 2007. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 07–397 Filed 1–30–07; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Heart, Lung, and Blood Institute Special Emphasis PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 Panel, February 20, 2007, 2 p.m. to February 20, 2007, 3 p.m., National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 which was published in the Federal Register on January 12, 2007, FR 07–100. The February 20, 2007 Meeting Panel Name was changed from VAD Technologies to Modified Hemoglobin Production. The meeting is closed to the public. Dated: January 24, 2007. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 07–398 Filed 1–30–07; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Dental & Craniofacial Research; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Dental and Craniofacial Research Special Emphasis Panel; 07–43, Review R03, F30. Date: February 12, 2007. Time: 1:30 p.m. to 2:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Raj K. Krishnaraju, PhD, MS, Scientific Review Administrator, Scientific Review Branch, National Inst. of Dental & Craniofacial Research, National Institutes of Health, 45 Center Dr. Rm 4AN 32J, Bethesda, MD 20892, 301–594–4864, kkrishna@nidcr.nih.gov. Name of Committee: National Institute of Dental and Craniofacial Research Special Emphasis Panel; 07–35, Review R21. Date: March 1, 2007. Time: 11 a.m. to 12 p.m. Agenda: To review and evaluate grant applications. E:\FR\FM\31JAN1.SGM 31JAN1

Agencies

[Federal Register Volume 72, Number 20 (Wednesday, January 31, 2007)]
[Notices]
[Page 4522]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-398]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Amended Notice of 
Meeting

    Notice is hereby given of a change in the meeting of the National 
Heart, Lung, and Blood Institute Special Emphasis Panel, February 20, 
2007, 2 p.m. to February 20, 2007, 3 p.m., National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892 which was published in 
the Federal Register on January 12, 2007, FR 07-100.
    The February 20, 2007 Meeting Panel Name was changed from VAD 
Technologies to Modified Hemoglobin Production. The meeting is closed 
to the public.

    Dated: January 24, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-398 Filed 1-30-07; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.